Skip to main content
. Author manuscript; available in PMC: 2017 Jun 2.
Published in final edited form as: Stat Biopharm Res. 2016 Jun 2;8(2):151–160. doi: 10.1080/19466315.2015.1133453

Figure 1.

Figure 1

Three-dimensional plot of fitted mixture model for both placebo and DHA. Back two walls represent 2.5 kg and 37 weeks cutpoints. Zeroing in on the third component, heights on the two figures are the same tells us the impact in lowering the risk of joint preterm birth and low birth weight with placebo relative to DHA.